Johnson & Johnson will pay 230 billion dollars in opioid cases
26 June Pharmaceutical Company Johnson & Johnson (NYSE: JNJ) announced the conclusion of a settlement agreement with the state of New York in the opioid case. For 9 years the company will pay the state 230-260 million dollars as compensation. More J&J will not be able to promote opioid drugs as locally, as well as at the national level.